Details
Carla Torrent, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Caterina del Mar Bonnin, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Anabel Martínez-Arán, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Jesús Valle, M.D., Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Benedikt L. Amann, M.D., Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Ana González-Pinto, M.D., Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
José Manuel Crespo, M.D., Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Ángela Ibáñez, M.D., Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Mari Paz Garcia-Portilla, M.D., Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Rafael Tabarés-Seisdedos, M.D., Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Celso Arango, M.D., Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Francesc Colom, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Brisa Solé, Psy.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Isabella Pacchiarotti, M.D., Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Adriane R. Rosa, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Jose Luis Ayuso-Mateos, M.D., Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Celia Anaya, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Patricia Fernández, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Ramon Landín-Romero, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Silvia Alonso-Lana, M.Sc.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Jordi Ortiz-Gil, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Bàrbara Segura, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Sara Barbeito, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Patricia Vega, Psy.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Miryam Fernández, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Amaia Ugarte, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Marta Subirà, M.B.B.S., M.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Ester Cerrillo, M.B.B.S., M.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Núria Custal, M.D., Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
José Manuel Menchón, M.D., Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Jerónimo Saiz-Ruiz, M.D., Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Jose Maria Rodao, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Sandra Isella, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Analucía Alegría, M.Sc.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Susana Al-Halabi, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Julio Bobes, M.D., Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Gonzalo Galván, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Pilar A. Saiz, M.D., Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Vicent Balanzá-Martínez, M.D., Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Gabriel Selva, M.D., Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Inmaculada Fuentes-Durá, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Patricia Correa, Psy.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
María Mayoral, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Guadalupe Chiclana, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Jessica Merchan-Naranjo, M.Sc.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Marta Rapado-Castro, Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Manel Salamero, M.D., Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Eduard Vieta, M.D., Ph.D.
From the Centers for Biomedical Research Network on Mental Health (CIBERSAM), Barcelona, Madrid, Vitoria, Oviedo, and Valencia, Spain; the Bipolar Disorder Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, University of Barcelona, Barcelona; the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; the European Network of Bipolar Research Expert Centers (ENBREC), Barcelona; the Department of Psychiatry, Autonomous University of Madrid, Research Institute of the Hospital de La Princesa, Madrid; FIDMAG Research Foundation, Barcelona; General Hospital of Granollers, Barcelona; Álava University Hospital, University of the Basque Country, Kronikgune, Vitoria, Spain; the Department of Psychiatry, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona; the Department of Clinical Sciences, Bellvitge Campus, Barcelona University, Barcelona; the Department of Psychiatry, Ramon y Cajal Hospital, Ramon y Cajal Institute of Health Research (IRYCIS), University of Alcala, Madrid; the Department of Psychiatry, University of Oviedo, Oviedo; the Department of Medicine, University of Valencia, Valencia, Spain; and the Gregorio Marañón University General Hospital and Health Research Institute (IISGM), Madrid.
Funding Information
Dr. Amann has served as a speaker for Bristol-Myers Squibb. Dr. González-Pinto has received grants from or served as consultant, adviser, or CME speaker for Almirall, AstraZeneca, Bristol-Myers Squibb, Cephalon, Eli Lilly, GlaxoSmithKline, Janssen-Cilag, Lundbeck, Merck, Novartis, Otsuka, Pfizer, Sanofi-Aventis, Schering-Plough, and the Spanish Ministry of Science and Innovation (CIBERSAM). Dr. Crespo has served as a consultant or speaker for AstraZeneca, Bristol-Myers Squibb, Janssen, Eli Lilly, GlaxoSmithKline, Lundbeck, Novartis, Otsuka, Pfizer, Sanofi-Sinthelabo, and Wyatt and has received grant support from FIS, Health Ministry, IDIBELL Foundation, and CIBERSAM. Dr. Arango has served as a consultant for or has received honoraria or grants from Abbott, AMGEN, AstraZeneca, Bristol-Myers Squibb, Caja Navarra, CIBERSAM, Alicia Koplowitz Foundation, Carlos III Health Institute, Janssen-Cilag, Lundbeck, Merck, Ministry of Science and Innovation, Ministry of Health, Ministry of Economy and Competitiveness, Mutua Madrileña, Otsuka, Pfizer, Roche, Servier, Takeda, and Schering-Plough. Dr. Colom has served as a speaker for Adamed, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Lundbeck, Otsuka, Pfizer, Sanofi-Aventis, and Tecnifar and as an adviser for MSD-Merck and Shire, and he has received copyright fees from Cambridge University Press, Solal Ed., Ars Médica, Giovani Fioriti Ed., Medipage, La Esfera de Los Libros, Morales i Torres Ed, Panamericana, Mayo Ed. & Columna. Dr. Ayuso-Mateos has provided expert testimony for Sanofi-Aventis. Dr. Menchon has received research grants from or served as a consultant or speaker for AGAUR, Almirall, AstraZeneca, Boehringer-Ingelheim, Eli Lilly, Janssen, Lundbeck, Medtronic, Novartis, Otsuka, Rovi, Servier, the Spanish Ministry of Health, the Spanish Ministry of Science and Innovation, and Wyeth. Dr. Rapado has received a Sara Borrell Health Research Fellowship from the Spanish Ministry of Economy and Competitiveness and an Alicia Koplowitz Grant for Short-Term Placements from the Alicia Koplowitz Foundation. Dr. Vieta has received grants, CME-related honoraria, or consulting fees from Alexza, Almirall, AstraZeneca, Bristol-Myers Squibb, Cephalon, Eli Lilly, Ferrer, Forest Research Institute, Gedeon Richter, GlaxoSmithKline, Janssen, Janssen-Cilag, Jazz, Johnson & Johnson, Lundbeck, Merck, Novartis, Organon, Otsuka, Pfizer, Pierre-Fabre, Qualigen, Roche, Sanofi-Aventis, Schering-Plough, Servier, Shire, Solvay, Takeda, Teva, CIBERSAM, the Seventh European Framework Programme (ENBREC), the Stanley Medical Research Institute, United Biosource Corporation, and Wyeth. The other authors report no financial relationships with commercial interests.
Supplementary Material
Supported by an ETS grant from the Spanish Ministry of Economy and Competitiveness (PI080180 and PI08/90825, PI08/90327, PI08/90675, PI08/90224, PI08/90654, PI08/90189, PI08/90916, PI08/90416, PI08/90094) PN 2008–2011, Carlos III Health Institute, General Subdepartment for Evaluation and Research Promotion; European Regional Fund, European Union, “Una manera de hacer Europa”; CIBERSAM; and the Commissioner for Universities and Research, Ministry of Innovation, Universities and Enterprise, Catalan Government (2009 SGR 1022 to the Bipolar Disorders Group).